Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Kingsville › NPI 1164868998
Clinic

Community Action Corporation of South Texas

Community Action Corporation of South Texas was paid $6.08M by Medicaid between Apr 2019 and Dec 2024, across 67 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 80% of everything it billed.

33Billing provider infoCOMMUNITY ACTION CORPORATION OF SOUTH TEXAS
KINGSVILLE, TX 78363
33aNPI1164868998assigned 05/20/2013
28Total paid$6.08M
24GClaims171,953
24DCodes billed67
24AFirst – last monthApr 2019 – Dec 2024
Compared with peers

Next to other Federally Qualified Health Center (FQHC) providers in Texas

Rank by total paid#41 of 248
Median peer was paid$796K
This provider vs. median7.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201963$12K
20204,496$235K
202136,455$1.55M
202245,689$1.58M
202350,034$1.54M
2024incomplete35,216$1.17M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 80% 30,616 21,913 $4.89M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 13% 18,028 14,872 $768K
D0999 Unspecified diagnostic procedure, by report 2.6% 924 792 $159K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.1% 2,821 2,313 $126K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 820 789 $36K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 742 711 $33K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 658 622 $27K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 457 444 $22K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 195 193 $10K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis <1% 68 58 $3K
0001A <1% 86 84 $2K
0002A <1% 55 50 $2K
55 more codes
92552 <1% 3,249 $1K
D0120 Dental checkup, returning patient <1% 253 $666.58
0072A <1% 13 $440.00
0071A <1% 19 $200.00
90658 <1% 99 $193.78
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 796 $147.59
87428 <1% 555 $50.25
D1206 Topical application of fluoride varnish <1% 72 $45.67
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,720 $16.41
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 212 $0.33
D1120 Dental cleaning, child <1% 27 $0.20
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 102 $0.20
90472 Immunization administration, each additional vaccine (list separately) <1% 1,357 $0.05
99173 <1% 3,439 $0.01
1159F <1% 20,503 $0.01
90686 <1% 726 $0.01
2010F <1% 12,543 $0.01
99050 <1% 114 $0.01
3028F 0% 2,023 $0.00
1160F 0% 20,038 $0.00
1033F 0% 401 $0.00
3078F 0% 405 $0.00
S5000 Prescription drug, generic 0% 48 $0.00
1003F 0% 226 $0.00
90756 0% 67 $0.00
90670 0% 127 $0.00
99051 0% 29 $0.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 0% 17 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 42 $0.00
90633 0% 12 $0.00
2001F 0% 14,888 $0.00
3008F 0% 18,707 $0.00
1170F 0% 533 $0.00
1220F 0% 3,090 $0.00
2000F 0% 1,098 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 0% 131 $0.00
1000F 0% 1,242 $0.00
1126F 0% 1,598 $0.00
36415 Collection of venous blood by venipuncture 0% 839 $0.00
3037F 0% 917 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 35 $0.00
90651 0% 39 $0.00
D1330 0% 208 $0.00
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 0% 385 $0.00
90688 0% 326 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 0% 34 $0.00
3074F 0% 592 $0.00
1125F 0% 201 $0.00
D0601 0% 137 $0.00
3079F 0% 104 $0.00
87807 0% 32 $0.00
99406 0% 47 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 35 $0.00
1036F 0% 18 $0.00
36416 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAWALT, ANN (EXECUTIVE DIRECTOR)
Parent organizationCOMMUNITY ACTION CORPORATION OF SOUTH TEXAS
Same official

Other billing entities under AWALT, ANN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.